Skip to main content
Clinical Trials/NCT05680350
NCT05680350CompletedNot Applicable

Plasma Levels of Micro RNA 203 and 210 Might Spare the Exploratory Laparoscopy in Case of un Explained Infertility With Suspected Endometriosis

Benha University2 sites in 1 country100 target enrollmentStarted: November 7, 2020Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
100
Locations
2
Primary Endpoint
grading of endometriosis

Study Overview

Brief Summary

The study targets to evaluate the role of estimation of plasma expression levels of gene of microRNAs 203 and 210 in helping to diagnose and grade endometriosis. The study included women with unexplained infertility and clinical picture suggestive of presence of endometriosis were divided randomly into two groups: Control and study groups. All patients underwent exploratory laparotomy for diagnosis and grading of endometriosis if present. Patients of study group gave blood samples for estimation of plasma expression levels of microRNA 203 and 210 using qRT-PCR procedure.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Diagnostic
Masking
Single (Participant)

Eligibility Criteria

Ages
30 Years to 45 Years (Adult)
Sex
Female
Accepts Healthy Volunteers
No

Inclusion Criteria

  • 30-45 years old
  • Unexplained infertility

Exclusion Criteria

  • Presence of other causes of infertility,
  • age out of the predetermined range,
  • the presence of immune disorders,
  • maintenance on immunosuppressive drugs

Outcomes

Primary Outcomes

grading of endometriosis

Time Frame: 8 months

The diagnostic performance of estimated plasma levels of microRNA for diagnosis and grading endometriosis

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Amr Sharaf Eldein

Assistant professor of gynecology

Benha University

Study Sites (2)

Loading locations...

Similar Trials